A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or S ézary Syndrome Previously Treated With Systemic Therapy

Conditions: Cutaneous T-Cell Lymphoma Interventions: Drug: Mogamulizumab Sponsors: Kyowa Kirin China Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials